Forscher von Johnson & Johnson im Interview „Mit einer Dosis Schutzwirkung von über 85 Prozent gegenüber schweren Verläufen“

März 22, 2021

Guenter Buchholz Medienspiegel

Forscher von Johnson & Johnson im Interview „Mit einer Dosis Schutzwirkung von über 85 Prozent gegenüber schweren Verläufen“

17.03.2021

Seit Ende der Woche ist der Impfstoff von Johnson & Johnson in der EU zugelassen. Entwickler Johan van Hoof über den Schutz, Mutanten und Nebenwirkungen.

Patrick Eickemeier

https://www.tagesspiegel.de/wissen/forscher-von-johnson-und-johnson-im-interview-mit-einer-dosis-schutzwirkung-von-ueber-85-prozent-gegenueber-schweren-verlaeufen/27003266.html

Ähnliche Beiträge

Proudly powered by WordPress | Theme: WPKites by Spicethemes

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.

Necessary

immer aktiv

Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.

Cookie	Dauer	Beschreibung
cookielawinfo-checkbox-analytics	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional	11 months	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy	11 months	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.

Functional

Performance

Analytics

Others

Forscher von Johnson & Johnson im Interview „Mit einer Dosis Schutzwirkung von über 85 Prozent gegenüber schweren Verläufen“

Tragen Sie sich für den wöchentlichen Medienüberblick - den Freitagsbrief - ein!

Gefällt mir:

Ähnliche Beiträge

Willkommen bei Aufklärung heute

Forscher von Johnson & Johnson im Interview „Mit einer Dosis Schutzwirkung von über 85 Prozent gegenüber schweren Verläufen“

Tragen Sie sich für den wöchentlichen Medienüberblick - den Freitagsbrief - ein!

Teilen mit:

Gefällt mir:

Ähnliche Beiträge